Literature DB >> 17434588

Punctate inner choroidopathy: a survey analysis of 77 persons.

Adam T Gerstenblith1, Jennifer E Thorne, Lucia Sobrin, Diana V Do, Syed Mahmood Shah, C Stephen Foster, Douglas A Jabs, Quan Dong Nguyen.   

Abstract

PURPOSE: To evaluate the demographic and clinical features of punctate inner choroidopathy (PIC).
DESIGN: Noncomparative survey. PARTICIPANTS: Persons with PIC who were in contact with the PIC Society.
METHODS: A survey was designed and posted on the Web site of the PIC Society, and persons diagnosed with PIC were invited to participate. Seventy-seven persons with PIC completed the survey. MAIN OUTCOME MEASURES: Demographics, presenting symptoms, disease manifestations, treatment regimens, and ocular complications.
RESULTS: Of the 77 participants who completed the survey, 90% were women, 97% Caucasian, and 85% myopic. The median age of participants was 30 years (range, 15-55). The median duration of disease at the time of survey completion was 3 years (range, <1-14). Reported presenting symptoms of PIC included scotomata (91%), blurred vision (86%), photopsias (73%), floaters (69%), photophobia (69%), metamorphopsia (65%), and loss of peripheral vision (26%). Eighty-five percent reported unilateral scotomata initially. Thirty-two percent of participants reported waxing and waning symptoms before treatment. The majority of participants (86%) had received treatment, most commonly with systemic (60%) and/or intraocular corticosteroids (22%). Fourteen percent of participants reported treatment with at least one immunosuppressive agent at some time during their disease. Sixty-nine percent had been diagnosed with choroidal neovascularization and 56% with subretinal fibrosis in at least one eye. In 75% of respondents, the onset of choroidal neovascularization occurred less than 1 year after the presenting symptoms of PIC, and in 79%, the onset of subretinal fibrosis occurred less than 1 year after the presenting symptoms.
CONCLUSIONS: In this survey of 77 persons with PIC, the majority of respondents were young, myopic, Caucasian women, who experienced unilateral scotoma and blurred vision as initial symptoms. The ocular complications choroidal neovascularization and subretinal fibrosis were present in the majority of participants in at least one eye and typically occurred within the first year of initial symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434588     DOI: 10.1016/j.ophtha.2006.10.047

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

Review 1.  Current approach in the diagnosis and management of posterior uveitis.

Authors:  S Sudharshan; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

Review 2.  Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.

Authors:  Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

4.  A 39-year-old woman with unilateral metamorphosias.

Authors:  Lígia Ribeiro; Sidnei Barge; Luís Silva; Arnaldo Brandão; Dália Meira
Journal:  Digit J Ophthalmol       Date:  2011-11-20

Review 5.  Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

Authors:  Hossein Nazari Khanamiri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2013-03-27       Impact factor: 6.048

Review 6.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

7.  Multifocal chorioretinitis with progressive subretinal fibrosis in a young child.

Authors:  Laura R Steeples; Jane Ashworth; Nicholas Jones
Journal:  BMJ Case Rep       Date:  2015-10-14

8.  [White dot syndromes : Principles, diagnostics, and treatment].

Authors:  Dominika Pohlmann; Sibylle Winterhalter; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

9.  [Punctate inner choroidopathy - Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control].

Authors:  S Weiss; R Winter; M W Meyer
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

Review 10.  [White dot syndrome].

Authors:  W Göbel
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.